Skip to content

Clinical trials

Completed Neurocognitive Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurocognitive Disorders Status: Completed Country / region: Canada Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20181
20223
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Anik Giguère1
Centre integre universitaire de sante et de services sociaux du Centre-Sud-de-l'Île-de-Montréal1
Inmune Bio, Inc.1
Sunnybrook Health Sciences Centre1
University of Calgary1
Women's College Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurocognitive Disorders6
Alzheimer Disease4
Cognitive Dysfunction3
Dementia2
Mental Disorders2
Nervous System Diseases2
Aphasia, Primary Progressive1
Brain Diseases1
Central Nervous System Diseases1
Confusion1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.